Sagimet Biosciences Inc. Series A
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMT and other ETFs, options, and stocks.About SGMT
Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).
SGMT Key Statistics
Stock Snapshot
The current Sagimet Biosciences Inc. Series A(SGMT) stock price is $5.01, with a market capitalization of 164.23M. The stock trades at a price-to-earnings (P/E) ratio of -2.88.
As of 2026-02-13, Sagimet Biosciences Inc. Series A(SGMT) stock has fluctuated between $5.00 and $5.29. The current price stands at $5.01, placing the stock +0.2% above today's low and -5.3% off the high.
The Sagimet Biosciences Inc. Series A(SGMT)'s current trading volume is 650.05K, compared to an average daily volume of 876.85K.
In the last year, Sagimet Biosciences Inc. Series A(SGMT) shares hit a 52-week high of $11.41 and a 52-week low of $1.73.
In the last year, Sagimet Biosciences Inc. Series A(SGMT) shares hit a 52-week high of $11.41 and a 52-week low of $1.73.
Analyst ratings
91%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.